Management of placenta accreta spectrum disorders in COVID 19 patients.
J Matern Fetal Neonatal Med
; 35(25): 8844-8847, 2022 Dec.
Article
in English
| MEDLINE | ID: covidwho-2250299
ABSTRACT
INTRODUCTION:
The COVID-19 pandemic has made it difficult to respond to demands in maternal health around the world. Placenta accreta spectrum (PAS) is one of the most severe obstetric conditions and usually requires the use of multiple health resources We describe the clinical results of the management of PAS patients during the COVID-19 pandemic and analyze how the pandemic may affect the functioning of a PAS team.METHODOLOGY:
This was a descriptive, retrospective study including all patients treated for PAS in two low- to middle-income country reference hospitals between January 2020 and March 2021. The clinical results of patients with SARS-CoV-2 infection during PAS surgery (Group 1) were compared with those of PAS patients without SARS-CoV-2 infection (Group 2).RESULTS:
One hundred forty-five patients undergoing surgery for PAS were included. Group 1 patients (11 cases) showed a longer operative time (250 min, IQR 200-300) and a higher frequency of intra- or postoperative complications (54.5%) than group 2 patients (180 min [IQR 125-240], and 17.9%).CONCLUSION:
Placenta accreta spectrum patients undergoing surgery during acute SARS-CoV-2 infection have a higher frequency of postoperative complications. PAS teams must prepare to modify their management protocols to minimize risks for patients and healthcare personnel.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Placenta Accreta
/
Placenta Previa
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Limits:
Female
/
Humans
/
Pregnancy
Language:
English
Journal:
J Matern Fetal Neonatal Med
Journal subject:
Obstetrics
/
Perinatology
Year:
2022
Document Type:
Article
Affiliation country:
14767058.2021.2005567
Similar
MEDLINE
...
LILACS
LIS